Polysaccharide‐modified liposomes and their application in cancer research
Chemical Biology & Drug Design · 2023-04 · 101 (4) · 998-1011
DOI: 10.1111/cbdd.14201 ↗At a glance
Übersichtsarbeit in Chemical Biology & Drug Design, published online on 2023-01-05. Written by Peichun Peng and 4 co-authors. Institution: International Zhuang Medical Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China. Major MEDLINE topics: Antineoplastic Agents, Neoplasms. Cited 49 times so far (Crossref); 98 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Province.
Abstract (original language)
Nanodrug delivery systems have been widely used in cancer treatment. Among these, liposomal drug carriers have gained considerable attention due to their biocompatibility, biodegradability, and low toxicity. However, conventional liposomes have several shortcomings, such as poor stability, rapid clearance, aggregation, fusion, degradation, hydrolysis, and oxidation of phospholipids. Polysaccharides are natural polymers of biological origin that exhibit structural stability, excellent biocompatibility and biodegradability, flexibility, non‐immunogenicity, low toxicity, and targetability. Therefore, they represent a promising class of polymers for the modification of the surface properties of liposomes to overcome their shortcomings. In addition, polysaccharides can be readily combined with other materials to develop new composite materials. Hence, they represent the optimal choice for liposomal modification to improve pharmacokinetics and clinical utility. Polysaccharide‐coated liposomes exhibit better stability, drug release kinetics, and cellular uptake than conventional liposomes. The oncologic application of polysaccharide‐coated liposomes has become a research hotspot. We summarize the preparation, physicochemical properties, and antineoplastic effects of polysaccharide‐coated liposomes to facilitate antitumor drug development.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- International Zhuang Medical Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China.
- Department of Traditional Chinese Medicine, Guangxi Academy of Medical Sciences, Nanning, China.
- Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China.
- Department of Basic Medical Science College, Guangxi University of Chinese Medicine, Nanning, China.
Funding
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province
Cite
APA
Peng, P., Chen, Z., Wang, M., Wen, B., & Deng, X. (2023). Polysaccharide‐modified liposomes and their application in cancer research. Chemical Biology & Drug Design, 101(4), 998-1011. https://doi.org/10.1111/cbdd.14201
Vancouver
Peng P, Chen Z, Wang M, Wen B, Deng X. Polysaccharide‐modified liposomes and their application in cancer research. Chemical Biology & Drug Design. 2023;101(4):998-1011. doi:10.1111/cbdd.14201
BibTeX
@article{Peng2023,
author = {Peng, Peichun and Chen, Zeshan and Wang, Miaodong and Wen, Bin and Deng, Xin},
title = {Polysaccharide‐modified liposomes and their application in cancer research},
journal = {Chemical Biology & Drug Design},
year = {2023},
volume = {101},
number = {4},
pages = {998--1011},
doi = {10.1111/cbdd.14201}
}
EUVIMED